For research teamsHelp me find a study
Back to all studies
CompletedNCT02942017

SAGE-547 90 μg/kg/h for depression

This study is completed in the United States. It is testing SAGE-547 90 μg/kg/h for depression.

DepressionDrugFrom 18 Years to 45 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether SAGE-547 90 μg/kg/h may be useful for adults experiencing depression.

What would participation involve?

Participants may receive SAGE-547 90 μg/kg/h, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adults with depression.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateJuly 2016
Recruitment status
Completed
Enrollment listed in the registry
108
Sponsor
Supernus Pharmaceuticals, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT02942017
Official title
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 32 sites
  • Sage Investigational Site
    Chandler, Arizona
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Rogers, Arkansas
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Lemon Grove, California
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Orange, California
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Ventura, California
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Miramar, Florida
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Pensacola, Florida
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Pinellas Park, Florida
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Wichita, Kansas
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Edgewood, Kentucky
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Owensboro, Kentucky
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Boston, Massachusetts
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Flowood, Mississippi
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Marlton, New Jersey
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Glen Oaks, New York
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Chapel Hill, North Carolina
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Charlotte, North Carolina
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Raleigh, North Carolina
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Columbus, Ohio
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Dayton, Ohio
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Baytown, Texas
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Richardson, Texas
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Sage Investigational Site
    Orem, Utah
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02942017. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Placebo, SAGE-547 90 μg/kg/h. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with depression; age range: From 18 Years to 45 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Supernus Pharmaceuticals, Inc., which appears to be a pharmaceutical company. Sponsor website: https://www.supernus.com. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.